quarta-feira, 7 de outubro de 2026
PesquisarExplore
pt.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 27, 2026

Broader Market Rallies on Tech Strength and Solid Earnings

View original at nasdaq.com
Broader Market Rallies on Tech Strength and Solid Earnings The S&P 500 Index ($SPX) (SPY) today is up +0.47%, the Dow Jones Industrials Index ($DOWI) (DIA) is down -0.84%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.87%…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • S&P 500 earnings growth expected to climb by 8.4% in Q4

    80% confidence

  • General Motors forecast full-year adjusted EPS of $11.00 to $13.00

    80% confidence

  • Deutsche Bank upgraded CoreWeave to buy from hold with price target of $140

    80% confidence

  • President Trump threatened 100% tariffs on US imports from Canada

    80% confidence

  • Excluding the Magnificent Seven megacap technology stocks, Q4 earnings expected to increase by 4.6%

    80% confidence

  • Sanmina forecast Q2 revenue of $3.1 billion to $3.4 billion

    80% confidence

  • Roper Technologies forecast 2026 adjusted EPS continuing operations of $21.30 to $21.55

    80% confidence

  • Micron Technology plans to invest $24 billion in Singapore and expand memory-chip capacity

    80% confidence

  • UnitedHealth Group forecast a decline in 2026 revenue, the first annual contraction in more than 30 years

    80% confidence

  • Senate Democrats threatened to block government funding deal over Department of Homeland Security/ICE funding

    80% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
A nossa leitura dos dados ›
Sinais que acompanhamos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,985
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,985 factos verificados com a fonte5,351 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Broader Market Rallies on Tech Strength and Solid Earnings — Source | Via News | pt.VIA.NEWS